摘要 |
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>5</SUB>, R<SUB>6a</SUB>, R<SUB>6b</SUB>, J, K, X and Z are as described in the specification.
|